[Results of ADVANCE trial conducted in type 2 diabetic patients].
D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D003226:Congresses as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D004338:Drug Combinations; D005060:Europe; D006801:Humans; D007190:Indapamide / Q000627:therapeutic use*; D008833:Microcirculation / Q000187:drug effects; D015337:Multicenter Studies as Topic / Q000379:methods*; D020913:Perindopril / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012955:Societies, Medical; D015996:Survival Rate
D004338:Drug Combinations; C494243:indapamide, perindopril drug combination; D007190:Indapamide; D020913:Perindopril